Yorktown Management & Research Co Increased Fidus Investment (FDUS) Holding; 6 Analysts Bullish Clinigen Group Plc (LON:CLIN)

February 12, 2018 - By wolcottdaily

Among 6 analysts covering Clinigen Group (LON:CLIN), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Clinigen Group had 68 analyst reports since July 29, 2015 according to SRatingsIntel. As per Wednesday, January 25, the company rating was maintained by Numis Securities. Stifel Nicolaus maintained the stock with “Buy” rating in Wednesday, September 23 report. N+1 Singer maintained the shares of CLIN in report on Wednesday, January 17 with “Buy” rating. As per Wednesday, July 20, the company rating was maintained by Numis Securities. Peel Hunt maintained the stock with “Buy” rating in Wednesday, March 15 report. The rating was maintained by Peel Hunt with “Buy” on Friday, February 24. Stifel Nicolaus maintained Clinigen Group Plc (LON:CLIN) rating on Wednesday, July 20. Stifel Nicolaus has “Buy” rating and GBX 800 target. N+1 Singer maintained it with “Buy” rating and GBX 800 target in Wednesday, July 29 report. The stock has “Buy” rating by N+1 Singer on Tuesday, September 22. Stifel Nicolaus maintained the shares of CLIN in report on Monday, May 22 with “Buy” rating. See Clinigen Group Plc (LON:CLIN) latest ratings:

01/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
18/01/2018 Broker: Berenberg Rating: Buy Old Target: GBX 1200.00 New Target: GBX 1220.00 Upgrade
17/01/2018 Broker: N+1 Singer Rating: Buy Old Target: GBX 1225.00 New Target: GBX 1225.00 Maintain
17/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
17/01/2018 Broker: Numis Securities Rating: Add New Target: GBX 1208.00 Maintain
29/11/2017 Broker: N+1 Singer Rating: Buy New Target: GBX 1225.00 Reinitiate
07/11/2017 Broker: RBC Capital Markets Rating: Outperform Old Target: GBX 1360.00 New Target: GBX 1360.00 Maintain
01/11/2017 Broker: Berenberg Rating: Hold New Target: GBX 1200.00 Initiates Starts
31/10/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
10/10/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 1200.00 New Target: GBX 1350.00 Upgrade

Yorktown Management & Research Co Inc increased Fidus Investment Corp (FDUS) stake by 14.58% reported in 2017Q3 SEC filing. Yorktown Management & Research Co Inc acquired 35,000 shares as Fidus Investment Corp (FDUS)’s stock rose 1.27%. The Yorktown Management & Research Co Inc holds 275,000 shares with $4.42 million value, up from 240,000 last quarter. Fidus Investment Corp now has $339.65M valuation. The stock decreased 0.23% or $0.0326 during the last trading session, reaching $13.8674. About 61,190 shares traded. Fidus Investment Corporation (NASDAQ:FDUS) has risen 12.11% since February 12, 2017 and is uptrending. It has underperformed by 4.59% the S&P500.

The stock increased 0.95% or GBX 9.5 during the last trading session, reaching GBX 1006. About 249,116 shares traded. Clinigen Group Plc (LON:CLIN) has 0.00% since February 12, 2017 and is . It has underperformed by 16.70% the S&P500.

Clinigen Group plc operates as a specialty pharmaceutical and services firm in the United Kingdom, Europe, the United States, and internationally. The company has market cap of 1.23 billion GBP. The Company’s Clinigen Clinical Trial Services business supplies and manages commercial medical products, including comparator drugs, adjuvant drugs, and rescue therapies for patients in clinical trials, as well as provides value added services. It has a 314.38 P/E ratio. The companyÂ’s Idis Managed Access business is involved in the consultancy, development, management, and implementation of managed access programs for biotechnology and pharmaceutical companies.

Yorktown Management & Research Co Inc decreased Microsoft Corp (NASDAQ:MSFT) stake by 4,200 shares to 17,000 valued at $1.27M in 2017Q3. It also reduced Apollo Coml Real Est Fin Inc (NYSE:ARI) stake by 120,000 shares and now owns 550,000 shares. Boeing Co (NYSE:BA) was reduced too.

Investors sentiment decreased to 1.4 in 2017 Q3. Its down 0.81, from 2.21 in 2017Q2. It dropped, as 7 investors sold FDUS shares while 13 reduced holdings. 10 funds opened positions while 18 raised stakes. 7.12 million shares or 4.90% more from 6.78 million shares in 2017Q2 were reported. Howe & Rusling owns 150 shares or 0% of their US portfolio. Moreover, Ativo Mgmt Ltd Llc has 0.25% invested in Fidus Investment Corporation (NASDAQ:FDUS). Oppenheimer And owns 27,331 shares or 0.01% of their US portfolio. Advsr Asset Mngmt has 0.11% invested in Fidus Investment Corporation (NASDAQ:FDUS). Macquarie Grp has 600 shares for 0% of their portfolio. Brown Brothers Harriman stated it has 11,828 shares or 0% of all its holdings. Optimum Invest Advisors holds 24,111 shares. Commonwealth Equity Svcs Inc reported 11,798 shares. 141,983 were accumulated by Blackrock. Baystate Wealth Mngmt Ltd Liability invested in 0% or 1,500 shares. Virtu Fin Ltd Limited Liability Company has invested 0% in Fidus Investment Corporation (NASDAQ:FDUS). Salzhauer Michael invested 0.14% of its portfolio in Fidus Investment Corporation (NASDAQ:FDUS). The California-based Ares Mngmt Limited Liability Com has invested 0.15% in Fidus Investment Corporation (NASDAQ:FDUS). Wells Fargo & Mn holds 3,075 shares. Guggenheim Cap Ltd owns 81,258 shares.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>